Introduction
The word dyscrasia comes from the Greek language and means "bad temperament" . In the older medical literature, the term was used to indicate disease. Currently the phrase blood dyscrasia was used to indicate a pathological condition of the cellular elements of the blood. An increase or decrease in the total number of red cells in a given patient is referred as polycythaemia or anemia respectively. A large population of atypical or neoplastic white blood cells within the blood constitutes leukemia. A subnormal number of platelets in the circulating blood ( thrombocytopenia) or loss of normal platelet function can lead to bleeding disorders or coagulopathies.
The ocular manifestations of blood dyscrasias are varied. Both the high vascularity and unique vascular anatomy of the eye play a role in the ocular manifestations of hematological diseases. The blood dyscrasias may present with ocular involvement, or ocular manifestations may arise during their course or ocular findings may arise as a consequence of treatment.
Independent of the pathogenic mechanism, anemia may cause nerve fiber layer hemorrhage and infarcts, white centre retinal hemorrhages and occasional vitreous hemorrhage. The severity of the hemorrhages is related to both the degree of anemia and presence of thrombocytopenia.
Ocular involvement in leukemia has long been recognized and virtually every ocular tissue may be affected. Involvement of orbit, lids, conjunctiva, sclera, uvea, retina and optic nerve are well documented. Cornea being avascular, is relatively spared and involvement of lens is unknown. The incidence of ocular involvement at sometime during the course of leukemia ranges as high as 90% 1 Ocular involvement may be because of direct invasion by leukemic cells or changes may be brought indirectly through various hemodynamic alterations. Guyer and associates 2 evaluated the relationship between leukemic retinopathy lesions and hematological parameters at the time of diagnosis. They found an association between the intraretinal hemorrhages and thrombocytopenia as well as low hematocrit while white cotton wool spots were not associated with hematological parameters.
Ocular manifestations of thrombocytopenia included papilloedema, extraocular muscle palsies and visual field defects, which usually result in concomitant CNS findings. Retinal findings consist of hemorrhages, vascular occlusions and serous detachments.
The significance of ocular changes in different blood dyscrasias, relationship between hematological alterations and the effect of treatment on these are not however properly understood.
Materials and Methods
A total of 135 patients of various age groups with different types of blood dyscrasias were studied between July 2007 and June 2008 at Regional Institute of Ophthalmology, Gauhati Medical College Hospital. The patients were diagnosed and treated by the departments of Hematology and Pediatrics of the same hospital. The study included freshly diagnosed cases to those receiving treatment and both indoor and outdoor patients. The findings of detailed history, blood and systemic examination findings and treatment history were recorded in the Proforma prepared for the study.
Ophthalmic examination and investigations included visual acuity for near and distant vision, Intraocular pressure measurement with a Schiotz tonometer, complete slit lamp bio microscopy of the anterior segment of the eyeball , Incidence of various types of anaemia : Amongst the 49 patients belonging to the group of anemia, 19 patients(38.78%) were diagnosed with iron deficiency anemia. 10 patients suffered from different thalassemias, whereas 9(18.36%) patients were diagnosed with aplastic anemia. Megaloblastic anemia accounted for 4 patients while the diagnosis for 5 patients was hemolytic anemia and another 2 patients 2 patients suffered from anemia of chronic disease. In the group of patients with hematological malignancies, acute leukemia patients showed the highest incidence of ocular changes. In total, 32 patients out of 44(73%) showed ocular changes with the incidence being 85% (22 out of 26) in AML and 55% (10 out of 18) in ALL. In chronic leukemia, 4 out of 10(40%) showed ocular involvement with CML showing an incidence of 43% (3 out of 7) and CLL showing an incidence of 33% (1 out of 3). Multiple myeloma patients had ocular changes in 50% (5 out of 10) cases. None of the patients with lymphomas (11 patients, 8 of NHL and 3 of HD) and MDS ( single case) showed any ocular manifestations. Chart 7: Incidence of ocular changes in anemia
In the group of patients with bleeding disorders, 3 patients with ITP and a single patient with hemophilia showed ocular changes. 
Discussion
Many studies and case reports highlighting the ocular manifestations of different blood dyscrasias are present in the literature. However, the results shown by them are not uniform and the significance of these changes and their relationship with hematological parameters have been reported differently by various studies. However, when reviewing the results of different studies, the methodology of the study has to be taken in to account, as both clinical and pathological studies are present.
In the present study, 135 patients with different blood dyscrasias were examined at R. I.O, Gauhati Medical College Hospital with 49 females and 86 males. The study population ranged from 7 months to 81years and 35 patients below 18 years and 100 patients in the adult group.
Patients with different blood disorders ranging from different types of anemia to leukemia, multiple myeloma, lymphoma and bleeding disorders were examined .Complete ophthalmic examination and note of blood counts were made.
In our study, 15 out of 49 suffering from different types of anemia showed ocular changes. Retinopathy was seen in 11 out 49(22.5%) patients with anemia and all showed retinal hemorrhages. Thus the incidence of retinopathy in anemia in the present study was similar to the earlier studies and the findings were similar too. In our study, 10 out of 135 patients had bleeding disorders, out of which 7 were suffering from Idiopathic thrombocytopenic purpura and 3 had hemophilia . 3 patients out of 7 (43%) and 1 out of 3(33%) showed ocular changes.
Holt and Gordon-Smith 7 in their study did not find any retinal hemorrhage in cases that had thrombocytopenia as the sole abnormality in peripheral blood. However, Kataria et al 8 in their study of fundus , examined two cases of thrombocytopenic purpura and found retinal hemorrhage in one of them. Rubenstein, Daniel and Harold 14 in their study of 123 patients with hemophilia reported ocular findings ( orbital or periorbital hemorrhage being most common) in 25 patients.
As the number of cases with bleeding disorders is less and majority of literature is in the form of isolated case reports, it is difficult to comment.
In our study , a total of 76 patients were diagnosed with hematological malignancies ,out of which 26 patients with AML, 18 with ALL, 7 with CML, 3 with CLL, 10 with multiple myeloma, 1 with MDS and 11 patients had lymphoma(8-NHL, 3-HD).The overall ocular changes in them was 53.5%(41 of 76). 13 (1990) 42 of 135 (31%) Our study (2008) 41 of 76 (53.5%)
The wide variation in incidence of ocular involvement in these studies may be ascribed to majority of them being pathological studies whereas ours was a clinical study. The wide variation may be due to some studies being pathological and some clinical and the dependence upon disease state. Vitreous hemorrhage was seen in only a single patient in the present study who was a female patient with acute myeloid leukemia. Schachat and co-workers 12 reported vitreous hemorrhage in3 patients and all the three patients in their series had myeloid leukemia.
The optic nerve and optic disc involvement was seen in 9 patirents as papilloedema , infiltration of the nerve( along with proptosis bilaterally), and pallor of the optic disc. Of the 5 patients with papilloedema, 2 had AML , 1 had ALL and 1 had CML. Holt and Gordon-Smith 7 found papilloedema in one case out of 33 case of acute leukemia. Kincaid and Green 1 have reported some type of optic nerve involvement to be slightly more common in acute leukemia (43 out of 233 eyes) than chronic leukemia (15 out of 97 eyes).
Overall 47 patients showed retinopathy. The difference in mean total leukocytic count(TLC) of the patients with acute leukemia showing retinopathy to those without retinopathy was not found statistically significant but for anemia patients, the mean TLC in patients with retinopathy was significantly lower than those without retinopathy (p= 0.0019). However it is difficult to explain the role of low count in causing retinopathy .When platelet count and hemoglobin concentration were analyzed, they were lower in those with retinopathy in leukemia, implying that difference in their mean being statistically significant (p=0.009 for platelets their and p= 0.005 for hemoglobin). This may imply that patients having acute leukemia with lower platelet count and lower hemoglobin concentration have greater chances of developing retinopathy. The statistical analysis also revealed that the means of platelet count and hemoglobin concentration were significantly lower in the patients with anemia and retinopathy than those without retinopathy (p<0.001 for platelet count, p=0.003 for hemoglobin}. Other parameters showed no significant difference due to small sample size.
Conclusion
Males were seen to be more affected than females. All the ocular structures except the lens showed changes in blood dyscrasias. Retina was the most common affected structure seen mainly in acute leukemia and retinal hemorrhage was the most common finding. As these results were not consistent between different disease groups, we may assume that lower platelet count and hemoglobin concentration are more predisposed to having retinopathy. Published literature is also not consistent on this subject. However, there was definite improvement of ocular changes with improvement in the blood picture with treatment. The present study was found to be satisfactory and within clinically acceptable limits of the different reported study groups.
